$9M Direct Offering at $2.00 Deepens Dilution for Cash-Strapped China SXT
SXTC is trading near its 52-week low of $1.25 (53% below the low) on elevated volume (54× avg).
Summary
China SXT is raising $9M via a registered direct offering of 4.5M units at $2.00 each, with warrants exercisable at $3.20. The offering price is a steep premium to the current $0.59 stock, but the structure is highly dilutive—adding 4.5M shares plus potential warrant exercise. This follows a $3.5M private placement in May, a $100M ATM launched in June, and a $30M dilutive prepaid financing in July. The company is burning cash after a sharp revenue decline and widening losses reported in its 20-F. The repeated capital raises at deeply distressed levels signal urgent funding needs and will further pressure the stock.
At the time of this announcement, SXTC was trading at $0.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $65.1M. The 52-week trading range was $1.25 to $1,046.98. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.